BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 11342442)

  • 1. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
    Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
    Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
    Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
    Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
    Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
    Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
    J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.
    Fehniger TA; Cooper MA; Nuovo GJ; Cella M; Facchetti F; Colonna M; Caligiuri MA
    Blood; 2003 Apr; 101(8):3052-7. PubMed ID: 12480696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
    Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-21 differentially affects human natural killer cell subsets.
    Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
    Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
    Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
    Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD; Daley J; Ritz J; Robertson MJ
    J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
    Jacobs R; Hintzen G; Kemper A; Beul K; Kempf S; Behrens G; Sykora KW; Schmidt RE
    Eur J Immunol; 2001 Oct; 31(10):3121-7. PubMed ID: 11592089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.